←
NurExone Biologic (TSXV: NRX) (Germany: J90)181 posts
NurExone Biologic (TSXV: NRX) (Germany: J90) avatar

NurExone Biologic (TSXV: NRX) (Germany: J90)

@NBiologic

NurExone Biologic is developing exosome-based therapies to regenerate nerves and recover function after Central Nervous System injuries.

◷ Joined May 2021▧ 71 Photos and videos
NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·Apr 13

What if paralysis 👨‍🦽 wasn’t permanent - or at least not untreatable? What if we could deliver regenerative signals to the central nervous system… through a simple intranasal spray? In our latest @ProgressPotent1 episode, @liorshal (CEO of @NBiologic) breaks down the science behind ExoPTEN - an exosome-based therapy designed to deliver siRNA and temporarily silence the PTEN signaling pathway, one of the nervous system’s key “brakes” on regeneration. 🚀 In preclinical models, this approach has shown something rarely seen in this field: meaningful functional recovery after severe spinal cord injury. We explore: - Why the central nervous system struggles to regenerate; - Whether exosomes can finally solve the delivery problem; - Dr. Shaltiel’s journey - from ion channel biophysics to leading one of the more ambitious bets in neuroregeneration; #Biotech #Neuroscience #SpinalCordInjury #RegenerativeMedicine #Exosomes #Neuroregeneration #GeneSilencing #FutureOfMedicine #HealthTech #Longevity @russopartners @HebrewU

35:56
NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·Feb 2

Over the past year, the term "exosome" entered mainstream conversation, but much of the visibility came from cosmetic or plant-derived products. The next phase looks very different. Do you agree that 2026 marks the shift to therapeutic reality for exosomes?

NurExone Biologic (TSXV: NRX) (Germany: J90) avatar
NurExone Biologic (TSXV: NRX) (Germany: J90)@NBiologic·21 Nov 2025

NurExone was nominated for The Galien Foundation Best Bridge Builder Award as we bridge academic research and applied innovation. #SeeyouinStockholm #GalienPrix #BridgeBuilding prnewswire.com/news-releases…